Skip to Content
Merck
  • Comparative ocular pressure elevation by medrysone, fluorometholone, and dexamethasone phosphate.

Comparative ocular pressure elevation by medrysone, fluorometholone, and dexamethasone phosphate.

Archives of ophthalmology (Chicago, Ill. : 1960) (1980-09-01)
J S Mindel, H O Tavitian, H Smith, E C Walker
ABSTRACT

In age-, race-, and sex-matched groups, the relative abilities of medrysone, fluorometholone, and dexamethasone phosphate to elevate intraocular pressure were compared in a masked manner. Compliance was controlled by drops being given by nursing personnel. The 18 male hospitalized volunteers received commercial preparations of one of the corticosteroids to each eye four times a day for six weeks. The relative ability of medrysone, fluorometholone, and dexamethasone phosphate to raise IOP was 1, 4, and 7.6, respectively.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
6α-Methyl-11β-hydroxyprogesterone